Impact of baseline serum IL‐8 on metastatic hormone‐sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805) is a research paper published in The Prostate (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA208254‐01
National Institutes of Health
Grant: U10CA180820
National Institutes of Health
Grant: U10CA180794
National Institutes of Health
Grant: UG1CA233180
National Institutes of Health
Grant: UG1CA233196
FWCI
1.32
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals